Your browser doesn't support javascript.
loading
Bedaquiline for multidrug-resistant TB in paediatric patients.
Moodliar, R; Aksenova, V; Frias, M V G; van de Logt, J; Rossenu, S; Birmingham, E; Zhuo, S; Mao, G; Lounis, N; Kambili, C; Bakare, N.
Afiliação
  • Moodliar R; Tuberculosis and HIV Investigative Network, King Dinuzulu Hospital, Sydenham, Durban, South Africa.
  • Aksenova V; National Medical Research Center for Phthisiopulmonology and Infectious Diseases, Moscow, Russian Federation.
  • Frias MVG; De La Salle Health Sciences Institute, Dasmariñas City, Cavite, the Philippines.
  • van de Logt J; Janssen Research & Development, Leiden, The Netherlands.
  • Rossenu S; Janssen Pharmaceutica, Beerse, Belgium.
  • Birmingham E; Janssen Research & Development, Raritan, NJ.
  • Zhuo S; Janssen Research & Development, Titusville, NJ, IQVIA, NC.
  • Mao G; Janssen Research & Development, Titusville, NJ.
  • Lounis N; Janssen Pharmaceutica, Beerse, Belgium.
  • Kambili C; Johnson & Johnson Global Public Health, New Brunswick, NJ, USA.
  • Bakare N; Janssen Research & Development, Titusville, NJ.
Int J Tuberc Lung Dis ; 25(9): 716-724, 2021 09 01.
Article em En | MEDLINE | ID: mdl-34802493
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Tuberculose Extensivamente Resistente a Medicamentos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Tuberculose Extensivamente Resistente a Medicamentos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article